Skip to main content

Table 5 Comparison of adverse effect that occurred in patients with pulmonary Mycobacterium avium complex disease between the control and levofloxacin (LVFX) groups

From: Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease

Adverse effects

Control group (n = 57)

LVFX group (n = 18)

Skin manifestation

9 (16)

4 (22)

Visual impairment

7 (12)

2 (11)

Gastrointestinal symptom

6 (11)

3 (17)

Hepatic dysfunction

1 ( 2 )

2 (11)

Miscellaneous

3 ( 5 )

1 ( 1 )

Total

21 (37)

10 (56)

  1. Values express as number (%) of patients. There was no significant difference in total and each adverse effect between both groups
Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us